Clorox Needs to Deliver on Innovation, Execution, RBC Says

MT Newswires Live
02/05

Clorox's (CLX) recovery in H2 fiscal 2026 will depend on its ability to deliver results from its largest innovation slate in years and complete its ERP transition, RBC said in a note Wednesday.

The company is rolling out new products across multiple brands, including Hidden Valley and Scentiva, along with a relaunch of its cat litter line, which should begin to show benefits in late fiscal Q3 as shelf resets begin, the report said.

The ERP system upgrade, which went live last July, is expected to finish by the end of Q3, it added.

"2H'26 momentum and investor confidence into 2027 hinges on CLX's ability to execute on its initiatives," the report said.

RBC kept its sector perform rating while cutting its price target to $132 from $142 on the back of moderating long-term margin expansion and higher long-term capital expenditure.

Price: 117.17, Change: +2.19, Percent Change: +1.90

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10